1,543 results on '"Capobianchi, Maria"'
Search Results
102. Virological and Serological Characterisation of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination Between December 2020 and March 2021
103. GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults
104. In Acute Dengue Infection, High TIM-3 Expression May Contribute to the Impairment of IFNγ Production by Circulating Vδ2 T Cells
105. Geographical variability affects CCHFV detection by RT-PCR
106. Effective screening strategy against SARS-CoV-2 on self-collected saliva samples in primary school setting: A pilot project
107. Recombinant interferon-α2b improves immune response to hepatitis B vaccination in haemodialysis patients: Results of a randomised clinical trial
108. A sensitive direct sequencing assay based on nested PCR for the detection of HBV polymerase and surface glycoprotein mutations
109. Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection
110. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy
111. Safety of Multiple Vaccinations and Durability of Vaccine-Induced Antibodies in an Italian Military Cohort 5 Years after Immunization
112. INMI1 Zika Virus NS4B Antagonizes the Interferon Signaling by Suppressing STAT1 Phosphorylation
113. Pleural Mesothelial Cells Modulate the Inflammatory/Profibrotic Response During SARS-CoV-2 Infection
114. Hepatitis E virus genotype 4 outbreak, Italy, 2011
115. Phylogenetic analysis of West Nile virus isolates, Italy, 2008-2009
116. Evaluation of the effects of human leukocyte IFN-α on the immune response to the HBV vaccine in healthy unvaccinated individuals
117. Influence of specific CD4+ T cells and antibodies on evolution of hypervariable region 1 during acute HCV infection
118. Ebolavirus and Marburgvirus: Insight the Filoviridae family
119. Alkhurma hemorrhagic fever in travelers returning from Egypt, 2010
120. Letter of concern re: “Analysis of Covid-19 and non-Covid-19 viruses, including influenza viruses, to determine the influence of intensive preventive measures in Japan. J. Clin. Virol. 2020; 129: 104543. doi:10.1016/j.jcv.2020.104543”
121. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test
122. Trend of respiratory pathogens during the COVID-19 epidemic
123. Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure
124. Predicting respiratory failure in patients infected by SARS-CoV-2 by admission sex-specific biomarkers
125. Additional file 1 of Multi-omics approach to COVID-19: a domain-based literature review
126. In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses
127. Virological and Serological Characterization of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination
128. Detection of SARS-CoV-2 in the community by nucleic acid amplification testing of saliva
129. ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients
130. Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine
131. Zika virus NS2A inhibits interferon signaling by degradation of STAT1 and STAT2
132. Identification of Human SARS-CoV-2 Monoclonal Antibodies from Convalescent Patients Using EBV Immortalization
133. Phylogenetic and Phylodynamic Analyses of HCV Strains Circulating among Patients Using Injectable Drugs in Central Italy
134. Letter of concern re: “Immunochromatographic test for the detection of SARS-CoV-2 in saliva. J Infect Chemother. 2021 Feb;27(2):384–386. doi: 10.1016/j.jiac.2020.11.016.”
135. An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19
136. Differential Expression of Werner and Bloom Syndrome Genes in the Peripheral Blood of HIV-1 Infected Patients
137. Trends in HIV prevalence among pregnant women in Italy, 1994 to 2002
138. Virus-Negative Necrotizing Coronary Vasculitis with Aneurysm Formation in Human SARS-CoV-2 Infection
139. The Easy-to-Use SARS-CoV-2 Assembler for Genome Sequencing: Development Study (Preprint)
140. Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
141. COVID-eVax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19
142. Immunogenicity and safety of BNT162b2 COVID‐19 vaccine in a chronic lymphocytic leukaemia patient
143. ESCA pipeline: Easy-to-use SARS-CoV-2 genome Assembler
144. Clinical Relevance of Torque Teno Virus (TTV) in HIV/HCV Coinfected and HCV Monoinfected Patients Treated with Direct-Acting Antiviral Therapy
145. Heparin protects human neural progenitor cells from Zika Virus-induced cell death and preserves their differentiation into mature neural-glia cells
146. Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab
147. No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison
148. GRAd-COV2, a gorilla adenovirus based candidate vaccine against COVID-19, is safe and immunogenic in young and older adults
149. Lumipulse G SARS-CoV-2 Ag assay evaluation using clinical samples from different testing groups
150. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.